Clinical Trial Update: Minimally Invasive Flap With Platelet Rich Fibrin or Growth Factor Enhanced Matrix in Treatment of Intrabony Defect [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating minimally invasive flap with platelet-rich fibrin or growth factor enhanced matrix for periodontal regeneration in intrabony defects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Disease

Drugs mentioned

• Platelet Rich Fibrin (platelet-rich fibrin)
• growth factor enhanced matrix (growth factor enhanced matrix)

Snippet

Sponsor: Tanta University | Conditions: Periodontal Regeneration | Phase 2 | Status: COMPLETED